In The News: Nevada Institute of Personalized Medicine
![Las Vegas Review Journal](/sites/default/files/styles/100_width_25_height/public/news_source/logo/las-vegas-review-journal.jpg?itok=IX9YBkgU)
With a new $11.4 million grant from the National Institutes of Health, UNLV wants to help the country move to a more data-driven approach to medicine.
![KNPR News](/sites/default/files/styles/100_width_25_height/public/news_source/logo/knpr.png?itok=2vihM0TC)
This week UNLV was awarded an $11.4 million grant from the National Institute of Health to advance the university’s efforts in personalized medicine.
![Conversation](/sites/default/files/styles/100_width_25_height/public/news_source/logo/the-conversation.png?itok=lKpI0f3e)
On May 6, the “All of Us” study started enrolling participants. This national study will be one of the largest ever examining the connection between genetics, behavior and medical outcomes, with a goal of 1 million or more participants. Anyone over the age of 18 in the U.S. can join.
![Las Vegas Business Press](/sites/default/files/styles/100_width_25_height/public/news_source/logo/bp-logo-230x52px.png?itok=QrH2Kmmv)
A revolution is taking place in medication and the Nevada Institute of Personalized Medicine at UNLV is at the forefront.
![KSNV-TV: News 3](/sites/default/files/styles/100_width_25_height/public/news_source/logo/ksnv-tv.png?itok=gEq9JPhc)
Perhaps this was on your mind this morning when you were getting ready for work: Pressure-induced Tetrahedral to Orthombic Phase Transition in MgF2.
From injectable HIV meds via CytoDyn's PRO 140 to HIV prevention via PrEP, from subdermal implants and cellular scissors to x-ray crystallography, this has been an amazing year for medical breakthroughs in HIV. Here's a roundup of some of the hottest new advances and studies in the field.
![KNPR News](/sites/default/files/styles/100_width_25_height/public/news_source/logo/knpr.png?itok=2vihM0TC)
It was 34 years ago, in 1981, that the first patients of the HIV virus were identified. Today, there remain 36.9 million people worldwide living with HIV.
![KNPR News](/sites/default/files/styles/100_width_25_height/public/news_source/logo/knpr.png?itok=2vihM0TC)
It was 34 years ago, in 1981, that the first patients of the HIV virus were identified. Today, there remain 36.9 million people worldwide living with HIV.
With millions of people infected with the HIV virus world-wide, a cure has yet to be found. The reason why vaccines and drugs are so hard to develop for this virus relates to both mutation and latency of the virus.
![Las Vegas Review Journal](/sites/default/files/styles/100_width_25_height/public/news_source/logo/las-vegas-review-journal.jpg?itok=IX9YBkgU)
A collection of biological codes sits in a library at UNLV. Much of the focus is learning how the codes can help cells fight off HIV. Researchers hope this work can be used to develop drugs much faster.
Needles, pills and patches may become tools of the past for some medications, including those used for oral pain medications, nail fungus and possibly diabetes.
![KNPR News](/sites/default/files/styles/100_width_25_height/public/news_source/logo/knpr.png?itok=2vihM0TC)
What would you do if there was a way to determine - with almost near certainty - what you might die from? Would you want to know? Would you want your doctor to know? Would you want your kids to know?